Theranostics Q1 Unclaimed
Theranostics is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology, Toxicology and Pharmaceutics (miscellaneous) with an H index of 158. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1525 €. The scope of the journal is focused on in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, personalized medicine. It has an SJR impact factor of 2,912 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,912.
Theranostics focuses its scope in these topics and keywords: cancer, theranostic, nanoparticles, vivo, imaging, breast, receptors, tumor, enhances, enable, ...
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1525 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
2,912
SJR Impact factor158
H Index317
Total Docs (Last Year)1864
Total Docs (3 years)24951
Total Refs23193
Total Cites (3 years)1864
Citable Docs (3 years)11.58
Cites/Doc (2 years)78.71
Ref/DocOther journals with similar parameters
Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1
Compare this journals
Comments